A Review of Clinical Trials of Human Papillomavirus Prophylactic Vaccines

This publication has 88 references indexed in Scilit:

• Human Papillomavirus Vaccine Introduction – The First Five Years
  Vaccine, 2012
• Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2011
• Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
  The Lancet Oncology, 2011
• Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
  Published by Elsevier ,2011
• Expression of codon optimized major capsid protein (L1) of human papillomavirus type 16 and 18 in Pichia pastoris; purification and characterization of the virus-like particles
  Published by Elsevier ,2011
• HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection
  Vaccine, 2011
• Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
  The Lancet Oncology, 2010
• Recombinant measles virus-HPV vaccine candidates for prevention of cervical carcinoma
  Vaccine, 2009
• An update of prophylactic human papillomavirus L1 virus-like particle vaccine clinical trial results
  Vaccine, 2008
• Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica
  Vaccine, 2008